PIR and breast cancer: Only a few of the identified piRNAs including piR-4987, piR-021285, piR-823, piR-932, piR-36712, piR-016658, and piR-016975 have been determined to possess regulatory functions, and, thus, may serve as potential biomarkers for the diagnosis or monitoring of BC treatment efficacy [222,229].